Unmet Needs in Darier’s Disease from a Patient’s Perspective: Lessons Learnt from the German Registry
DOI:
https://doi.org/10.2340/actadv.v104.19663Keywords:
Darier’s disease, genodermatosis, orphan disease, disease burden, registryAbstract
The MDHHgermany registry was initiated to characterize the “real-life” situation of affected individuals with Darier’s disease (DD; Morbus Darier, MD) and Hailey-Hailey disease (HH), including their treatment and healthcare. To gain deeper insights into medical care of patients with DD, various aspects such as demographics, subjective symptoms, patient satisfaction with medical care, past and current therapies were explored. Patients with diagnosed DD were included. Subjective symptoms such as itch, pain and burning sensation were assessed. Individual therapy goals were recorded and patients assessed previous/current therapies along with satisfaction of medical care and treatment. A total of 55 patients were recruited; 47 patients were eligible for the analysis. Pruritus was rated the most bothersome symptom. Some 42.6% had not received systemic treatment so far or systemic therapies were rated ineffective (32.6%). Most commonly oral retinoids were prescribed, followed by corticosteroids. Patient satisfaction with medical care and treatment proved to be mediocre. This “real-life” data show an alarming unmet need regarding patients’ satisfaction with medical care and treatment, evidenced by the reported lack of disease control. Further studies and interventions are needed to improve the spectrum of available therapies. MDHHgermany provides a foundational platform for future clinical trials, epidemiological studies, and pathophysiological analyses.
Downloads
References
Cooper SM, Burge SM. Darier's disease: epidemiology, pathophysiology, and management. Am J Clin Dermatol 2003; 4: 97-105.
https://doi.org/10.2165/00128071-200304020-00003 DOI: https://doi.org/10.2165/00128071-200304020-00003
Rogner DF, Lammer J, Zink A, Hamm H. Darier and Hailey-Hailey disease: update 2021. J Dtsch Dermatol Ges 2021; 19: 1478-1501.
https://doi.org/10.1111/ddg.14619 DOI: https://doi.org/10.1111/ddg.14619
Miyauchi Y, Daiho T, Yamasaki K, Takahashi H, Ishida-Yamamoto A, Danko S, et al. Comprehensive analysis of expression and function of 51 sarco(endo)plasmic reticulum Ca2+-ATPase mutants associated with Darier disease. J Biol Chem 2006; 281: 22882-22895.
https://doi.org/10.1074/jbc.M601966200 DOI: https://doi.org/10.1074/jbc.M601966200
Sakuntabhai A, Dhitavat J, Burge S, Hovnanian A. Mosaicism for ATP2A2 mutations causes segmental Darier's disease. J Invest Dermatol 2000; 115: 1144-1147.
https://doi.org/10.1046/j.1523-1747.2000.00182.x DOI: https://doi.org/10.1046/j.1523-1747.2000.00182.x
Burge SM, Wilkinson JD. Darier-White disease: a review of the clinical features in 163 patients. J Am Acad Dermatol 1992; 27: 40-50.
https://doi.org/10.1016/0190-9622(92)70154-8 DOI: https://doi.org/10.1016/0190-9622(92)70154-8
Holzberg M BR, de Berker D, Thomas L. Chapter 6: The nail in dermatological disease. Hoboken, NJ: Wiley; 2012.
https://doi.org/10.1002/9781118286715.ch6 DOI: https://doi.org/10.1002/9781118286715.ch6
Munro CS. The phenotype of Darier's disease: penetrance and expressivity in adults and children. Br J Dermatol 1992; 127: 126-130.
https://doi.org/10.1111/j.1365-2133.1992.tb08044.x DOI: https://doi.org/10.1111/j.1365-2133.1992.tb08044.x
Dodiuk-Gad R, Cohen-Barak E, Ziv M, Shani-Adir A, Amichai B, Zlotogorski A, et al. Health-related quality of life among Darier's disease patients. J Eur Acad Dermatol Venereol 2013; 27: 51-56.
https://doi.org/10.1111/j.1468-3083.2011.04355.x DOI: https://doi.org/10.1111/j.1468-3083.2011.04355.x
Harris A, Burge SM, Dykes PJ, Finlay AY. Handicap in Darier's disease and Hailey-Hailey disease. Br J Dermatol 1996; 135: 959-963.
https://doi.org/10.1046/j.1365-2133.1996.d01-1102.x DOI: https://doi.org/10.1046/j.1365-2133.1996.d01-1102.x
Rogner DZ, A. MDHHgermany. p. https://www.derma-allergie.med.tum.de/fuer-patienten/darier-und-hailey-hailey.html.
Rogner D, Heimerl L, Heyer S, Biedermann T, Sattler E, Zink A. Patients' perspective, quality of life and treatment goals in Hailey-Hailey disease: Lessons learned from the German National Registry. J Eur Acad Dermatol Venereol 2024; 38: 419-429.
https://doi.org/10.1111/jdv.19583 DOI: https://doi.org/10.1111/jdv.19583
Lyon JA, Garcia-Milian R, Norton HF, Tennant MR. The use of Research Electronic Data Capture (REDCap) software to create a database of librarian-mediated literature searches. Med Ref Serv Q 2014; 33: 241-252.
https://doi.org/10.1080/02763869.2014.925379 DOI: https://doi.org/10.1080/02763869.2014.925379
Weisshaar E, Bentz P, Apfelbacher C, Haufe E, Heinrich L, Heratizadeh A, et al. Itching in atopic dermatitis: patient- and physician-reported outcomes in the German Atopic Dermatitis Registry TREATgermany. Acta Derm Venereol 2023; 103: adv00854.
https://doi.org/10.2340/actadv.v103.4426 DOI: https://doi.org/10.2340/actadv.v103.4426
Amar Y, Rogner D, Silva RL, Foesel BU, Ud-Dean M, Lagkouvardos I, et al. Darier's disease exhibits a unique cutaneous microbial dysbiosis associated with inflammation and body malodour. Microbiome 2023; 11: 162.
https://doi.org/10.1186/s40168-023-01587-x DOI: https://doi.org/10.1186/s40168-023-01587-x
Hsieh CY, Tsai TF. Use of H-1 antihistamine in dermatology: more than itch and urticaria control: a systematic review. Dermatol Ther (Heidelb) 2021; 11: 719-732.
https://doi.org/10.1007/s13555-021-00524-w DOI: https://doi.org/10.1007/s13555-021-00524-w
Savignac M, Simon M, Edir A, Guibbal L, Hovnanian A. SERCA2 dysfunction in Darier disease causes endoplasmic reticulum stress and impaired cell-to-cell adhesion strength: rescue by Miglustat. J Invest Dermatol 2014; 134: 1961-1970.
https://doi.org/10.1038/jid.2014.8 DOI: https://doi.org/10.1038/jid.2014.8
Zhao Q, Fu F, Fu X, Wang Z, Liu H, Zhang F. Three novel mutations of the ATP2A2 gene in Chinese patients with Darier disease. Australas J Dermatol 2019; 60: e171-e172.
https://doi.org/10.1111/ajd.12957 DOI: https://doi.org/10.1111/ajd.12957
Hulatt L, Burge S. Darier's disease: hopes and challenges. J R Soc Med 2003; 96: 439-441. DOI: https://doi.org/10.1258/jrsm.96.9.439
https://doi.org/10.1177/014107680309600906 DOI: https://doi.org/10.1177/014107680309600906
Vieira ML, de Paula Samorano L, da Matta Rivitti-Machado MC, de Oliveira ZNP. Darier disease: long-term treatment with systemic retinoids at a tertiary hospital. J Dtsch Dermatol Ges 2020; 18: 628-630.
https://doi.org/10.1111/ddg.14113 DOI: https://doi.org/10.1111/ddg.14113
Haber RN, Dib NG. Management of Darier disease: a review of the literature and update. Indian J Dermatol Venereol Leprol 2021; 87: 14-21.
https://doi.org/10.25259/IJDVL_963_19 DOI: https://doi.org/10.25259/IJDVL_963_19
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Danielle Rogner, Laura Heimerl, Tilo Biedermann, Elke Sattler, Alexander Zink
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
